19 Dec 2022 FINTEPLA®▼ (fenfluramine) oral solution recommended for approval in the EU for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) Member news
06 Dec 2022 Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity Member news
28 Nov 2022 Monkeys not Donkeys, QbD Group’s life science marketing and communication agency, strengthens its team Member news
15 Nov 2022 Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia Member news
08 Nov 2022 New Idylla™ EGFR study shows reduction of time-to-treatment by 48% for lung cancer patients Member news
27 Oct 2022 Indigo Diabetes incorporates fully owned subsidiary in the US and appoints Peter J. Devlin as President, Indigo Medical US Inc. Member news
21 Oct 2022 ExeVir Bio forges ahead with unique next generation COVID-19 therapy and appoints Dr. Jeanne Bolger as Chair of the Board of Directors Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
